info@seagull-health.com
SeagullHealth
语言:
search
new
Market Price of Genuine Ivosidenib
506
Article source: Seagull Pharmacy
Sep 03, 2025

Ivosidenib is a therapeutic drug for acute myeloid leukemia (AML) targeting specific gene mutations, and its market price has attracted significant attention from patients and their families. So, what is the market price of genuine Ivosidenib?

Market Price of Genuine Ivosidenib

The market price of genuine Ivosidenib varies depending on regions, sales channels, and purchase timing. The following is a detailed analysis of the market price of genuine Ivosidenib:

The Ivosidenib product produced by Lucius (Laos) with a specification of 250mg*60 tablets is priced at approximately 1,206 US dollars per box. The market price of genuine Ivosidenib is affected by multiple factors. When purchasing the drug, patients should fully understand the market situation, choose formal channels, and pay attention to policy developments to ensure the cost-effectiveness of medication.

Purchase Channels for Ivosidenib

Understanding the purchase channels for Ivosidenib is particularly important for patients. Legal purchase channels not only ensure the quality of the drug but also provide patients with necessary after-sales services:

1. Purchase from Hospital Pharmacies

Hospital pharmacies are one of the main purchase channels for Ivosidenib. Under the guidance of doctors, patients can purchase Ivosidenib through hospital pharmacies. This method ensures the formal source of the drug and allows patients to receive professional guidance from doctors.

2. Online Pharmacies and Cross-border E-commerce Platforms

In addition to hospital pharmacies, online pharmacies and cross-border e-commerce platforms also provide convenience for patients to purchase Ivosidenib. These platforms usually cooperate with pharmaceutical companies to offer direct sales channels. However, it is necessary to pay attention to choosing formal and qualified platforms for purchase.

There are various purchase channels for Ivosidenib, and patients should select formal and legal channels. During the purchase process, patients need to identify the authenticity of the drug to ensure the legitimacy of medication.

Medication Guide for Ivosidenib

As a prescription drug, the dosage and administration of Ivosidenib must strictly follow the doctor's guidance. Correct medication methods not only ensure the therapeutic effect but also reduce the occurrence of adverse reactions:

1. Dosage and Administration

The recommended dose of Ivosidenib is 500mg, taken orally once a day. Patients should take the drug at a fixed time to avoid missed doses or repeated doses. When taking the drug, high-fat meals should be avoided to prevent affecting the drug's efficacy.

2. Precautions and Adverse Reactions

During the use of Ivosidenib, patients should regularly monitor indicators such as blood cell count, blood biochemistry, and electrocardiogram. Attention should be paid to possible adverse reactions such as fatigue, joint pain, and diarrhea. If any abnormalities occur, patients should seek medical advice in a timely manner.

The use of Ivosidenib must strictly comply with medical advice to ensure correct dosage and administration. Patients should pay attention to monitoring their physical reactions and handle adverse reactions promptly. Through reasonable medication methods, Ivosidenib can bring better therapeutic effects to patients.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Ivosidenib(Tibsovo)
Ivosidenib(Tibsovo)
Adult patients with relapsed or refractory acute myeloid leukemia.
WeChat Scan
Free Inquiry
Recommended Articles
Ivosidenib Package Insert
Ivosidenib is a targeted therapeutic drug for relapsed or refractory acute myeloid leukemia (AML) in patients with isocitrate dehydrogenase 1 (IDH1) mutation. This article will provide a comprehensive...
Ivosidenib Price
Ivosidenib is a targeted therapeutic drug for relapsed or refractory acute myeloid leukemia (AML) in patients with IDH1 mutations. This article will explore three aspects—price, side effects, and miti...
How Much Does Ivosidenib Cost?
Ivosidenib is a targeted drug used for treating acute myeloid leukemia (AML) in patients with specific gene mutations. Its price varies depending on the manufacturer and specifications. For patients a...
Annual Treatment Cost of Ivosidenib
Ivosidenib is a targeted drug for specific gene mutations, and its high treatment costs have become a focus of concern for patients. This article will analyze three aspects—annual treatment costs, the...
Dosage of cemipalimab (Cemiplimab)
Cemiplimab is an immune checkpoint inhibitor antibody targeting PD-1, used in the treatment of various advanced or metastatic tumors. Mastering the proper usage and dosage is crucial for exerting the ...
How to Use Cemiplimab
Cemiplimab is an immune checkpoint inhibitor used in the treatment of specific cancers. It activates the patient's own immune system to attack tumor cells by blocking the PD-1 pathway.How to Use C...
Side Effects of Cemiplimab
As an immune checkpoint inhibitor, Cemiplimab has shown significant efficacy in the treatment of malignant tumors such as cutaneous squamous cell carcinoma. However, its use may also be accompanied by...
Indications for Cemiplimab
Cemiplimab (trade name: LIBTAYO) is an innovative immunotherapeutic drug that activates the human immune system to fight tumors by targeting the PD-1 pathway.I. Indications for Cemiplimab1. Cutaneous ...
Related Articles
What Are the Indications of Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important isocitrate dehydrogenase-1 (IDH1) inhibitor, providing an innovative treatment option for patients with various malignant tumors harboring IDH1 mutations.What Are ...
Dosage, Administration and Recommended Dose of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is the first targeted therapy indicated for acute myeloid leukemia (AML) with IDH1 mutations, and its standardized administration is crucial for treatment efficacy.Dosage, Adminis...
Channels for Purchasing Tibsovo® (Ivosidenib)
Tibsovo® (Ivosidenib) is an oral targeted therapy indicated for IDH1 mutations. It has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of acute myeloid...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved